Brivaracetam and Levetiracetam Suppress Astroglial L-Glutamate Release through Hemichannel via Inhibition of Synaptic Vesicle Protein
Open accessThe DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
To explore the pathophysiological mechanisms of antiseizure and adverse behavioural/psychiatric effects of brivaracetam and levetiracetam, in the present study, we determined the effects of brivaracetam and levetiracetam on astroglial L-glutamate release induced by artificial high-frequency oscillation (HFO) bursts using ultra-high-performance liquid chromatography. Additionally, the effects of brivaracetam and levetiracetam on protein expressions of connexin43 (Cx43) and synaptic vesicle protein 2A (SV2A) in the plasma membrane of primary cultured rat astrocytes were determined using a capillary immunoblotting system. Acutely artificial fast-ripple HFO (500 Hz) burst stimulation use-dependently increased L-glutamate release through Cx43-containing hemichannels without affecting the expression of Cx43 or SV2A in the plasma membrane, whereas acute physiological ripple HFO (200 Hz) stimulation did not affect astroglial L-glutamate release or expression of Cx43 or SV2A. Contrarily, subchronic ripple HFO and acute pathological fast-ripple HFO (500 Hz) stimulations use-dependently increased L-glutamate release through Cx43-containing hemichannels and Cx43 expression in the plasma membrane. Subchronic fast-ripple HFO-evoked stimulation produced ectopic expression of SV2A in the plasma membrane, but subchronic ripple HFO stimulation did not generate ectopic SV2A. Subchronic administration of brivaracetam and levetiracetam concentration-dependently suppressed fast-ripple HFO-induced astroglial L-glutamate release and expression of Cx43 and SV2A in the plasma membrane. In contrast, subchronic ripple HFO-evoked stimulation induced astroglial L-glutamate release, and Cx43 expression in the plasma membrane was inhibited by subchronic levetiracetam administration, but was not affected by brivaracetam. These results suggest that brivaracetam and levetiracetam inhibit epileptogenic fast-ripple HFO-induced activated astroglial transmission associated with hemichannels. In contrast, the inhibitory effect of therapeutic-relevant concentrations of levetiracetam on physiological ripple HFO-induced astroglial responses probably contributes to the adverse behavioural/psychiatric effects of levetiracetam.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Both agents reduce pathologic astroglial glutamate release, supporting glutamatergic homeostasis during periods of heightened network demand [203,204].”
From Synaptic Plasticity—Intrinsic Excitability and Antidepressant Discovery (2026) · cites this paper as [203]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017
Hiemke, C., Bergemann, N., Clement, H., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., et al. (2018) · Pharmacopsychiatry · doi:10.1055/s-0043-116492 · Cited by 1,446 · cited 1×
“It has been considered that the candidate therapeutic-relevant concentrations of brivaracetam and levetiracetam range from 2 to 6 μM and from 70 to 270 μM, respectively [35,36].”
The cognitive impact of antiepileptic drugs
Eddy, C. M., Rickards, H. E., & Cavanna, A. E. (2011) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285611417920 · Cited by 404
Brain neural patterns and the memory function of sleep
Girardeau, G., & Lopes-dos-Santos, V. (2021) · Science · doi:10.1126/science.abi8370 · Cited by 293 · cited 2×
“It is speculated that sleep spindle/ripple HFO bursts provide the formation and/or maintenance of a part of cognitive function [29].”
BackgroundEpilepsy, Antiepileptic Drugs, and Aggression: An Evidence-Based Review
Brodie, M. J., Besag, F., Ettinger, A. B., Mula, M., Gobbi, G., Comai, S., Aldenkamp, A. P., & Steinhoff, B. J. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.012021 · Cited by 288 · cited 1×
“Considering the impacts on quality of life, adverse behavioural or psychiatric events induced by antiseizure drugs play important roles in the decisions regarding antiepileptic medication [6,11].”
BackgroundHippocampal sharp-wave ripples linked to visual episodic recollection in humans
Norman, Y., Yeagle, E. M., Khuvis, S., Harel, M., Mehta, A. D., & Malach, R. (2019) · Science · doi:10.1126/science.aax1030 · Cited by 270 · cited 1×
“Recent psychophysiological studies have accumulated findings that ripple HFO and sleep spindle play important roles in the generation of several subdomains of cognition, such as perceptual/sensory integration, reasoning ability, and memory consolidation [29,61,62].”
BackgroundAdverse antiepileptic drug effects: Toward a clinically and neurobiologically relevant taxonomy
Perucca, P., Carter, J., Vahle, V., & Gilliam, F. G. (2009) · Neurology · doi:10.1212/01.wnl.0000345667.45642.61 · Cited by 237 · cited 1×
“Considering the impacts on quality of life, adverse behavioural or psychiatric events induced by antiseizure drugs play important roles in the decisions regarding antiepileptic medication [6,11].”
BackgroundRibeiro-Rodrigues, T. M., Martins-Marques, T., Morel, S., Kwak, B. R., & Girão, H. (2017) · Journal of Cell Science · doi:10.1242/jcs.200667 · Cited by 203 · cited 1×
“The six assembling connexins (connexon) in the plasma membrane connect with the other connexon in the plasma membrane in various neighbouring cells, neurons, astrocytes, oligodendrocytes, and microglia, forming a gap junction [20].”
BackgroundCramer, J. (2003) · Epilepsy & Behavior · doi:10.1016/s1525-5050(03)00005-2 · Cited by 190
Mutch, S. A., Kensel-Hammes, P., Gadd, J. C., Fujimoto, B. S., Allen, R. W., Schiro, P. G., Lorenz, R. M., Kuyper, C. L., Kuo, J. S., Bajjalieh, S. M., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.3805-10.2011 · Cited by 185 · cited 1×
“SV2A is ubiquitously expressed in various structures in the central nervous system but selectively expressed in the synaptic vesicle membrane, with five copies in each vesicle [12,13].”
BackgroundKlitgaard, H., Matagne, A., Nicolas, J., Gillard, M., Lamberty, Y., De Ryck, M., Kaminski, R. M., Leclercq, K., Niespodziany, I., Wolff, C., et al. (2016) · Epilepsia · doi:10.1111/epi.13340 · Cited by 168
How to record high‐frequency oscillations in epilepsy: A practical guideline
Zijlmans, M., Worrell, G. A., Dümpelmann, M., Stieglitz, T., Barborica, A., Heers, M., Ikeda, A., Usui, N., & Le Van Quyen, M. (2017) · Epilepsia · doi:10.1111/epi.13814 · Cited by 165 · cited 5×
“Functionally, the ripple HFO and fast-ripple HFO are considered to contribute to respective physiological sleep-related [31,39] and pathological epilepsy-related events [27,38], whereas the detailed acute/subchronic impacts of HFOs on transmission have not been clarified fully.”
BackgroundMethodInfluentialOpening of connexin 43 hemichannels is increased by lowering intracellular redox potential
Retamal, M. A., Schalper, K. A., Shoji, K. F., Bennett, M. V. L., & Sáez, J. C. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702456104 · Cited by 162 · cited 1×
“1 mM range during neuronal hyperactivity [13,26,44,49].”
Forsythe, I., Butler, R., Berg, I., & McGuire, R. (1991) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.1991.tb14917.x · Cited by 129
Hansen, C. C., Ljung, H., Brodtkorb, E., & Reimers, A. (2018) · Behavioural Neurology · doi:10.1155/2018/2064027 · Cited by 124
Steinhoff, B. J., Klein, P., Klitgaard, H., Laloyaux, C., Moseley, B. D., Ricchetti-Masterson, K., Rosenow, F., Sirven, J. I., Smith, B., Stern, J. M., et al. (2021) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2021.107939 · Cited by 118 · cited 1×
“A recent systematic review reported that switching from levetiracetam to brivaracetam could improve adverse behavioural/psychiatric reactions induced by levetiracetam [32].”
BackgroundSteinig, I., von Podewils, F., Möddel, G., Bauer, S., Klein, K. M., Paule, E., Reif, P. S., Willems, L. M., Zöllner, J. P., Kunz, R., et al. (2017) · Epilepsia · doi:10.1111/epi.13768 · Cited by 115
The Synaptic Vesicle Glycoprotein 2: Structure, Function, and Disease Relevance
Stout, K. A., Dunn, A. R., Hoffman, C., & Miller, G. W. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.9b00351 · Cited by 112 · cited 5×
“SV2A selectively expresses in the vesicular membrane, and contributes to transmitter release as a Ca2+ sensor in the Ca2+-dependent exocytosis mechanisms [14]; however, the hyperactivation of fusion/docking of the plasma membrane with vesicular membrane through the exocytosis process produces the ectopic SV2A in the p…”
BackgroundInfluentialBrivaracetam add-on for refractory focal epilepsy: A systematic review and meta-analysis
Lattanzi, S., Cagnetti, C., Foschi, N., Provinciali, L., & Silvestrini, M. (2016) · Neurology · doi:10.1212/wnl.0000000000002545 · Cited by 106
Wood, M. D., & Gillard, M. (2017) · Epilepsia · doi:10.1111/epi.13638 · Cited by 101 · cited 1×
“Modulation of the function of synaptic vesicle protein type 2A (SV2A) has been considered to play an important role in the suppression of epileptic seizure, since highaffinity SV2A-binding compounds, levetiracetam and brivaracetam, are first-line antiseizure drugs [1,2].”
BackgroundKanazawa, K., Matsumoto, R., Imamura, H., Matsuhashi, M., Kikuchi, T., Kunieda, T., Mikuni, N., Miyamoto, S., Takahashi, R., & Ikeda, A. (2014) · Clinical Neurophysiology · doi:10.1016/j.clinph.2014.05.028 · Cited by 100 · cited 1×
“HFO is categorised by two frequency ranges: relatively slow physiological ripple HFO (80–250 Hz and tens of milliseconds duration), which is observed during sleep spindle; and epileptogenic fast-ripple HFO (250–500 Hz and milliseconds duration), which is detected prior to the initiation of epileptic seizure in the epi…”
MethodFerraris, M., Cassel, J., de Vasconcelos, A. P., Stéphan, A., & Quilichini, P. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.02.025 · Cited by 99 · cited 2×
“Functionally, the ripple HFO and fast-ripple HFO are considered to contribute to respective physiological sleep-related [31,39] and pathological epilepsy-related events [27,38], whereas the detailed acute/subchronic impacts of HFOs on transmission have not been clarified fully.”
BackgroundControl of neurotransmitter release by an internal gel matrix in synaptic vesicles
Reigada, D., Díez-Pérez, I., Gorostiza, P., Verdaguer, A., Gómez de Aranda, I., Pineda, O., Vilarrasa, J., Marsal, J., Blasi, J., Aleu, J., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0336914100 · Cited by 98 · cited 1×
“Intracellular acidic shift promotes adsorption among SV2A and other vesicular proteins via negatively charged proteoglycans [60].”
BackgroundVillanueva, V., López-González, F. J., Mauri, J. A., Rodriguez-Uranga, J., Olivé-Gadea, M., Montoya, J., Ruiz-Giménez, J., Zurita, J., & the BRIVA-LIFE study group (2019) · Acta Neurologica Scandinavica · doi:10.1111/ane.13059 · Cited by 84
Hirsch, M., Hintz, M., Specht, A., & Schulze-Bonhage, A. (2018) · Seizure · doi:10.1016/j.seizure.2018.07.017 · Cited by 82
Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy
Ben‐Menachem, E., Edrich, P., Vleymen, B. V., Sander, J. W. A. S., & Schmidt, B. (2003) · Epilepsy Research · doi:10.1016/s0920-1211(02)00247-4 · Cited by 80
Fasciani, I., Temperán, A., Pérez-Atencio, L. F., Escudero, A., Martínez‐Montero, P., Molano, J., Gómez‐Hernández, J. M., Paı́no, C. L., González‐Nieto, D., & Barrio, L. C. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.03.040 · Cited by 78 · cited 1×
“During the opening of the Cx43-containing hemichannel, its opening probability is rapidly increased and decreased by depolarisation and hyperpolarisation, respectively [47].”
BackgroundSteinhoff, B. J., Bacher, M., Bucurenciu, I., Hillenbrand, B., Intravooth, T., Kornmeier, R., Kurth, C., Stockinger, J., & Staack, A. M. (2017) · Seizure · doi:10.1016/j.seizure.2017.03.010 · Cited by 76
Zhang, N., Gordon, S. L., Fritsch, M. J., Esoof, N., Campbell, D. G., Gourlay, R., Velupillai, S., Macartney, T., Peggie, M., van Aalten, D. M. F., et al. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.4248-14.2015 · Cited by 72
Walrave, L., Pierre, A., Albertini, G., Aourz, N., Bundel, D. D., Eeckhaut, A. V., Vinken, M., Giaume, C., Leybaert, L., & Smolders, I. J. (2018) · Glia · doi:10.1002/glia.23341 · Cited by 68 · cited 3×
“These subchronic ripple HFO and fast-ripple HFO-evoked stimulations enhanced astroglial L-glutamate release via the activation of astroglial Cx43-containing hem channels, si c both astroglial L-g utamate r lease induced subchronic ripple HFO and f st-ripple HFO-evoked stimulations (for 7 ere inhibited by 20 μM TATGAP1…”
BackgroundMethodLévesque, M., Behr, C., & Avoli, M. (2014) · Seizure · doi:10.1016/j.seizure.2014.11.008 · Cited by 59 · cited 4×
“The effects of levetiracetam on ripple HFO or sleep spindle remain to be clinically clarified; however, two preclinical studies revealed that levetiracetam predominantly inhibited fast-ripple HFO compared to ripple HFO [30,31].”
BackgroundInfluentialSleep Spindles and Intellectual Ability: Epiphenomenon or Directly Related?
Fang, Z., Sergeeva, V., Ray, L. B., Viczko, J., Owen, A. M., & Fogel, S. M. (2017) · Journal of Cognitive Neuroscience · doi:10.1162/jocn_a_01034 · Cited by 57 · cited 1×
“Recent psychophysiological studies have accumulated findings that ripple HFO and sleep spindle play important roles in the generation of several subdomains of cognition, such as perceptual/sensory integration, reasoning ability, and memory consolidation [29,61,62].”
BackgroundExpression of connexin 43 in the human epileptic and drug-resistant cerebral cortex
Garbelli, R., Frassoni, C., Condorelli, D. F., Trovato Salinaro, A., Musso, N., Medici, V., Tassi, L., Bentivoglio, M., & Spreafico, R. (2011) · Neurology · doi:10.1212/wnl.0b013e31820f2da6 · Cited by 56 · cited 1×
“Increased expression of astroglial hemichannels in the regions close to epileptic focus of patients with epilepsy [41,42] and epileptic animal models [43–46] was observed.”
BackgroundPulsed DC Electric Field–Induced Differentiation of Cortical Neural Precursor Cells
Chang, H., Lee, Y.-S., Tang, T. K., & Cheng, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158133 · Cited by 54 · cited 1×
“Both ripple-evoked and fast-ripple-evoked stimulations were set at a square-wave DC pulse output, with a magnitude of 300 mV/mm2 [26,72].”
BackgroundSon, Y.-J., Scranton, T. W., Sunderland, W. J., Baek, S. J., Miner, J. H., Sanes, J. R., & Carlson, S. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.451 · Cited by 52 · cited 3×
“SV2A selectively expresses in the vesicular membrane, and contributes to transmitter release as a Ca2+ sensor in the Ca2+-dependent exocytosis mechanisms [14]; however, the hyperactivation of fusion/docking of the plasma membrane with vesicular membrane through the exocytosis process produces the ectopic SV2A in the p…”
BackgroundSafety and tolerability of adjunctive brivaracetam in epilepsy: In-depth pooled analysis
Brandt, C., Klein, P., Badalamenti, V., Gasalla, T., & Whitesides, J. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.106864 · Cited by 52
Okada, M., Yoshida, S., Zhu, G., Hirose, S., & Kaneko, S. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.045 · Cited by 52 · cited 1×
“Indeed, zonisamide supresses carbamazepine-resistant epileptic seizures by extracellular acidification via carbonic anhydrase inhibition [26,57,58].”
BackgroundSelf-citationLevetiracetam has a time- and stimulation-dependent effect on synaptic transmission
Yang, X., & Rothman, S. M. (2009) · Seizure · doi:10.1016/j.seizure.2009.07.004 · Cited by 51 · cited 1×
“The acute effects of brivaracetam and levetiracetam on astroglial transmission required exposure to these agents for longer than 120 min [13,34,37].”
BackgroundIkeda, A., Takeyama, H., Bernard, C., Nakatani, M., Shimotake, A., Daifu, M., Matsuhashi, M., Kikuchi, T., Kunieda, T., Matsumoto, R., et al. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.01.014 · Cited by 51 · cited 5×
“Functionally, the ripple HFO and fast-ripple HFO are considered to contribute to respective physiological sleep-related [31,39] and pathological epilepsy-related events [27,38], whereas the detailed acute/subchronic impacts of HFOs on transmission have not been clarified fully.”
BackgroundInfluentialAstrocytic Connexin43 Channels as Candidate Targets in Epilepsy Treatment
Walrave, L., Vinken, M., Leybaert, L., & Smolders, I. J. (2020) · Biomolecules · doi:10.3390/biom10111578 · Cited by 49 · cited 1×
“Acute systemic administration of TAT-GAP19, which selectively inhibits the Cx43-containing hemichannel without affecting the Cx43-containing gap junction, and carbenoxolone, a non-selective inhibitor of both hemichannel and gap junction, suppress the duration and severity of several epileptic models [50,51].”
BackgroundFukuyama, K., Fukuzawa, M., Shiroyama, T., & Okada, M. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14974 · Cited by 47 · cited 3×
“Furthermore, after ADSHE onset, both physiological sleep-related ripple HFO and epileptogenic fast-ripple HFO can contribute to ictogenesis or the generation of ADSHE seizures; however, the contribution of fast-ripple HFO to ADSHE seizure development was much greater than that of ripple HFO [19,26,44,52,53].”
BackgroundSelf-citationLevetiracetam inhibits neurotransmitter release associated with CICR
Fukuyama, K., Tanahashi, S., Nakagawa, M., Yamamura, S., Motomura, E., Shiroyama, T., Tanii, H., & Okada, M. (2012) · Neuroscience Letters · doi:10.1016/j.neulet.2012.03.056 · Cited by 46 · cited 1×
“Additionally, ectopic SV2A in the plasma membrane induced by hyper-neuronal activations probably generates the matrix with laminin type 1 receptor in the extracellular space or connexin43 (Cx43) in the plasma membrane [13,16,17].”
BackgroundSelf-citationPannexin 1 activation and inhibition is permeant‐selective
Nielsen, B. S., Toft‐Bertelsen, T. L., Lolansen, S. D., Anderson, C. L., Nielsen, M. S., Thompson, R. J., & MacAulay, N. (2019) · The Journal of Physiology · doi:10.1113/jp278759 · Cited by 46
Harlow, M. L., Szule, J. A., Xu, J., Jung, J. H., Marshall, R. M., & McMahan, U. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069410 · Cited by 44 · cited 1×
“SV2 is considered to be the mainstay of luminal protein for the matrix with other vesicular proteins in the synaptic vesicle membrane due to the length of its luminal domain, which is longer than the diameter of the vesicle lumen [59].”
BackgroundHu, Q., Zhang, F., Teng, W., Hao, F., Zhang, J., Yin, M., & Wang, N. (2017) · Journal of Neurology · doi:10.1007/s00415-017-8621-x · Cited by 41
Therapeutic Drug Monitoring of Newer Antiepileptic Drugs: A Randomized Trial for Dosage Adjustment
Aícua‐Rapún, I., André, P., Rossetti, A. O., Ryvlin, P., Hottinger, A. F., Decosterd, L. A., Buclin, T., & Nový, J. (2019) · Annals of Neurology · doi:10.1002/ana.25641 · Cited by 41 · cited 1×
“It has been considered that the candidate therapeutic-relevant concentrations of brivaracetam and levetiracetam range from 2 to 6 μM and from 70 to 270 μM, respectively [35,36].”
BackgroundOkada, M., Fukuyama, K., Shiroyama, T., & Murata, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197019 · Cited by 39 · cited 1×
“Contrarily, a single connexon is one of the responsible molecules in tripartite synaptic transmission (among the presynaptic and postsynaptic neurones as well as their intimate association with surrounding glia cells) [19,21,22] as a hemichannel, which also regulates ionic homeostasis, including ionic movement regulat…”
BackgroundSelf-citationContribution of non-selective membrane channels and receptors in epilepsy
García‐Rodríguez, C., Tobar, I. D. B., Duarte, Y., Barrio, L. C., & Sáez, J. C. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107980 · Cited by 39 · cited 5×
“These findings suggest that the activation of astroglial hemichannels plays an important role in ictogenesis and epileptic neuronal damage, since an activated hemichannel releases large amounts of various excitatory modulators, such as L-glutamate, D-serine, ATP, K+, and eicosanoids [18,19,25].”
BackgroundInfluentialLee, S., Lee, H.-W., Heo, K., Shin, D. J., Song, H.-K., Kim, O.-J., Lee, S., Kim, S., & Lee, B.-I. (2010) · Seizure · doi:10.1016/j.seizure.2010.10.006 · Cited by 38
Astroglial Connexin43 as a Potential Target for a Mood Stabiliser
Okada, M., Oka, T., Nakamoto, M., Fukuyama, K., & Shiroyama, T. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010339 · Cited by 38 · cited 3×
“Contrarily, a single connexon is one of the responsible molecules in tripartite synaptic transmission (among the presynaptic and postsynaptic neurones as well as their intimate association with surrounding glia cells) [19,21,22] as a hemichannel, which also regulates ionic homeostasis, including ionic movement regulat…”
BackgroundSelf-citationTopiramate and zonisamide prevent paradoxical intoxication induced by carbamazepine and phenytoin
Yamamura, S., Hamaguchi, T., Ohoyama, K., Sugiura, Y., Suzuki, D., Kanehara, S., Nakagawa, M., Motomura, E., Matsumoto, T., Tanii, H., et al. (2009) · Epilepsy Research · doi:10.1016/j.eplepsyres.2009.01.015 · Cited by 37 · cited 1×
“Indeed, zonisamide supresses carbamazepine-resistant epileptic seizures by extracellular acidification via carbonic anhydrase inhibition [26,57,58].”
BackgroundSelf-citationZhang, L., Li, S., Li, H., & Zou, X. (2016) · Seizure · doi:10.1016/j.seizure.2016.05.004 · Cited by 36
Fukuyama, K., Ueda, Y., & Okada, M. (2020) · Pharmaceuticals · doi:10.3390/ph13060117 · Cited by 36
Self-citationFukuyama, K., Okubo, R., Murata, M., Shiroyama, T., & Okada, M. (2020) · Cells · doi:10.3390/cells9020414 · Cited by 35
Self-citationBrivaracetam in adults with drug-resistant epilepsy and psychiatric comorbidities
Theochari, E. G., Cock, H. R., Lozsádi, D. A., Galtrey, C. M., Arevalo, J., & Mula, M. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2018.11.032 · Cited by 34
Altered expression of pannexin proteins in patients with temporal lobe epilepsy
Jiang, T., Long, H., Ma, Y., Long, L., Li, Y., Feng, L., Zhou, P., Yuan, C., & Xiao, B. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1739 · Cited by 33 · cited 1×
“Increased expression of astroglial hemichannels in the regions close to epileptic focus of patients with epilepsy [41,42] and epileptic animal models [43–46] was observed.”
BackgroundCan rodent models elucidate the pathomechanisms of genetic epilepsy?
Okada, M. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15443 · Cited by 31
Self-citationFukuyama, K., Fukuzawa, M., Shiroyama, T., & Okada, M. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110070 · Cited by 29 · cited 2×
“Furthermore, after ADSHE onset, both physiological sleep-related ripple HFO and epileptogenic fast-ripple HFO can contribute to ictogenesis or the generation of ADSHE seizures; however, the contribution of fast-ripple HFO to ADSHE seizure development was much greater than that of ripple HFO [19,26,44,52,53].”
BackgroundSelf-citationFukuyama, K., Fukuzawa, M., & Okada, M. (2020) · Pharmaceuticals · doi:10.3390/ph13050099 · Cited by 29
Self-citationOkada, M., Fukuyama, K., Shiroyama, T., & Ueda, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111462 · Cited by 28 · cited 8×
“Additionally, ectopic SV2A in the plasma membrane induced by hyper-neuronal activations probably generates the matrix with laminin type 1 receptor in the extracellular space or connexin43 (Cx43) in the plasma membrane [13,16,17].”
BackgroundMethodSelf-citationEffects of levetiracetam on astroglial release of kynurenine‐pathway metabolites
Fukuyama, K., & Okada, M. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14491 · Cited by 27 · cited 5×
“The acute effects of brivaracetam and levetiracetam on astroglial transmission required exposure to these agents for longer than 120 min [13,34,37].”
BackgroundMethodSelf-citationFukuyama, K., Fukuzawa, M., Okubo, R., & Okada, M. (2020) · Pharmaceuticals · doi:10.3390/ph13040058 · Cited by 27
Self-citationFukuyama, K., & Okada, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218142 · Cited by 27 · cited 7×
“ADSHE onset needs to produce interictal discharges including fast-ripple HFO during the critical period of ADSHE onset [19,44,52].”
BackgroundSelf-citationFukuyama, K., & Okada, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22115623 · Cited by 26 · cited 2×
“Expression of Cx43 in the plasma membrane is regulated by the trafficking processes via several intracellular signalling pathways, such as Erk, Akt, and adenosine monophosphate-activated protein kinase (AMPK) [23,33,54,55].”
BackgroundSelf-citationFukuyama, K., & Okada, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112846 · Cited by 19 · cited 16×
“Both ripple-HFO and fast-ripple-HFO evoked stimulations were performed using a busdrive amplifier (SEG-3104MG, Miyuki Giken, Tokyo, Japan).”
BackgroundMethodSelf-citationShiroyama, T., Fukuyama, K., & Okada, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810013 · Cited by 18
Self-citationFukuyama, K., Motomura, E., Shiroyama, T., & Okada, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112750 · Cited by 18 · cited 4×
“According to our previous studies, subchronic administration of target agent and HFO-evoked stimulations were performed during after 21 days of culture (DIV21) and DIV28 (for 7 days) [13,23,26,33].”
BackgroundMethodSelf-citationLevetiracetam, an Antiepileptic Drug has Neuroprotective Effects on Intracranial Hemorrhage Injury
Imai, T., Sugiyama, T., Iwata, S., Nakamura, S., Shimazawa, M., & Hara, H. (2020) · Neuroscience · doi:10.1016/j.neuroscience.2020.01.036 · Cited by 16 · cited 1×
“Levetiracetam prevented brain damage via the suppression of Erk signalling [56].”
BackgroundAstroglial connexins in epileptogenesis
Yang, T., Qian, F., Liu, L., Peng, X., Huang, J., Ren, B., & Tang, F.-R. (2020) · Seizure · doi:10.1016/j.seizure.2020.11.022 · Cited by 16 · cited 2×
“Although the present study revealed that fast-ripple HFO enhanced astroglial L-glutamate release through the activated hemichannel, the mechanisms of increasing astroglial L-glutamate release induced by acute fast-ripple HFO-evoked stimulation have two possibilities; namely, the enhancement of hemichannel activity [13…”
BackgroundMotaghi, S., Sayyah, M., Babapour, V., & Mahdian, R. (2017) · Iranian Biomedical Journal · doi:10.18869/acadpub.ibj.21.3.167 · Cited by 14
Lacosamide and Levetiracetam Have No Effect on Sharp-Wave Ripple Rate
Kudláček, J., Chvojka, J., Pošusta, A., Kovacova, L., Hong, S. B., Weiss, S. A., Volna, K., Marusič, P., Otáhal, J., & Jiruška, P. (2017) · Frontiers in Neurology · doi:10.3389/fneur.2017.00687 · Cited by 14
Fukuyama, K., & Okada, M. (2021) · Pharmaceuticals · doi:10.3390/ph14111116 · Cited by 12 · cited 2×
“Expression of Cx43 in the plasma membrane is regulated by the trafficking processes via several intracellular signalling pathways, such as Erk, Akt, and adenosine monophosphate-activated protein kinase (AMPK) [23,33,54,55].”
BackgroundSelf-citationSimeone, T. A., Heruye, S., Kostansek, J. A., Yeh, M. Y., Matthews, S. A., Samson, K. K., & Simeone, K. A. (2021) · Brain Sciences · doi:10.3390/brainsci11060787 · Cited by 8 · cited 1×
“A recent preclinical study revealed that carbamazepine concentration-dependently suppressed ripple HFO [66].”
Background
Cited by
Therapeutic Potential and Limitation of Serotonin Type 7 Receptor Modulation
Fukuyama, K., Motomura, E., & Okada, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032070 · Cited by 36
Self-citationOkada, M., Fukuyama, K., & Motomura, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23169103 · Cited by 17
“A recent study reported that ripple burst could be involved in ictogenesis in the networks that have acquired vulnerability to epileptogenesis [49,51].”
BackgroundSelf-citationPresynaptic antiseizure medications-basic mechanisms and clues for their rational combinations
Czapińska-Ciepiela, E. K., Łuszczki, J., Czapiński, P., Czuczwar, S. J., & Lasoń, W. (2024) · Pharmacological Reports · doi:10.1007/s43440-024-00603-7 · Cited by 13
Anti-seizure Medications: Challenges and Opportunities
Tandon, N., Radosavljević, M., Vučević, D. B., Radenković, M., Jančić, J., & Samardžić, J. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273275793231030060833 · Cited by 16
Ismail, F. S., Faustmann, P. M., Kümmel, M.-L., Förster, E., Faustmann, T. J., & Corvace, F. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.995861 · Cited by 12
“The antiseizure effect of BRV was discussed to be mediated by suppression of SV2A and subsequent inhibition of turnover prolongation of Cx43 hemichannels in the plasma membrane (Fukuyama and Okada, 2022).”
Background
Metadata
- Authors
- Fukuyama, K., & Okada, M.
- Affiliations
- Mie University (JP)
- Corresponding author
- Okada, Motohiro
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2022-04-19
- Volume
- 23
- Issue
- 9
- Pages
- 4473
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC9101419
- OpenAlex
- W4280525086
- Cited by
- 22
- References
- 72
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 5 · 2023: 3 · 2022: 4
- FWCI
- 2.77
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Japan Epilepsy Research Foundation (JERF TENKAN 21008)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Connexins and lens biology
- Keywords
- brivaracetam, levetiracetam, connexin 43, hemichannels, SV2A, epileptogenic activity, antiepileptic drugs, astrocytes
- MeSH terms
- Levetiracetam, Animals, Anticonvulsants, Astrocytes, Pyrrolidinones, Synaptic Vesicles, Connexin 43, Glutamic Acid, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.